期刊文献+

磁共振波谱分析在骨与软组织病变良恶性鉴别诊断中的应用 被引量:5

下载PDF
导出
摘要 磁共振波谱分析(magnetic resonance spectrosco-py,MRS)是一种研究活体组织生化信息及代谢功能状态的无创技术。目前应用于临床的MRS主要有2种,即1H-MRS和31 P-MRS,且多集中在31 P-MRS在肌肉骨骼系统的应用[1-3]。2006年1月至2010年12月,笔者搜集了58例经临床病理证实且1H-MRS资料完整的骨与软组织病变患者的病历资料,
出处 《中医正骨》 2011年第4期30-32,共3页 The Journal of Traditional Chinese Orthopedics and Traumatology
基金 2005年河南省重点科技攻关项目(0523030500)
  • 相关文献

参考文献11

  • 1Wang CK,Li CW,Hsieh TJ,et al.cterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy:initial results[J].Radiology,2004,232(2):599-605.
  • 2Oya N,Aoki J,Shinozaki T,et al.Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors:an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodennal tumor[J].Radiat Med,2000,18(3):193-198.
  • 3周春香,孟悛非,陈应明,罗柏宁,张中伟.磁共振氢质子波谱在下肢骨-软组织疾病中应用初探[J].临床放射学杂志,2003,22(12):1035-1038. 被引量:12
  • 4Millis K,Weybright P,Campbell N,et al.Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy[J].Magn Reson Med,1999,41(2):257-267.
  • 5Mukherji SK,Sehiro S,Castillo M,et al.Proton MR spectroscopy of squamous cell carcinoma of the upper aerrodigestive tract:in vitro characteristics[J].AJNR Am J Neuroradiol,1996,17(8):1485-1490.
  • 6Verstraete KL,De Deene Y,Roels H,et al.Benign and ma1ignant musculoskeletal lesions:dynamic contrast-enhanced MR imaging-parametric"first-pass"images depict tissue vascularization and perfusion[J].Radiology,1994,192(3):835-843.
  • 7Ma LD,Frassica FJ,McCarthy EF.et al.Benign and malignant musculoskeletal masses:MR imaging differentiation with rim-to-center differential enhancement ratios[J].Radiology,1997,202(3):739-744.
  • 8孟悛非,吕衍春,吕凤华,程晓玫,张朝晖,陈应明,梁康福,陈美霞,邹文星,阮超美.增强MR灌注成像在骨骼-软组织肿瘤良恶性鉴别诊断中的价值[J].中华放射学杂志,2001,35(8):578-583. 被引量:47
  • 9郭会利,张敏,程敬亮.早期动态MRI增强斜率值对肌肉骨骼系统良恶性肿瘤的鉴别诊断价值及临床研究[J].实用放射学杂志,2008,24(2):217-220. 被引量:3
  • 10Negendank W.Studies of human tumors by MRS:a review[J].NMR Biomed,1992,5(5):303-324.

二级参考文献24

  • 1[7]Schick F, Duda S, Laniado M, et al. Special MR methods for primary bone tumors: Ⅱ. Volume selective 1 H-spectroscopy. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, 1993, 159:325
  • 2[8]Joseph R, Kim MC, Mitchell DS, et al. Human breast lesions: characterization with proton. MR spectroscopy. Radiology, 1998, 209:269
  • 3[10]Wang Z, Zimmerman RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR, 1996, 167:191
  • 4[11]Lin CS, Fertikh D, Davis D, et al. 2D CSI proton MR spectroscopy of human spinal vertebra: feasibility studies. J Magn Reson Imaging, 2000, 11:287
  • 5[12]Negendank W. Studies of human tumors by MRS. NMR Biomed, 1992, 5:303
  • 6[1]Schellinger D, Lin CS, Hatipoglu HG,et al. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR, 2001, 22:1620
  • 7[2]Schellinger D, Lin CS, Fertikh D, et al. Normal lumbar vertebrae: anatomic, age, and sex variance in subjects at proton MR spectroscopy-initial experience. Radiology, 2000, 215:910
  • 8[3]Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR, 1996, 17:1
  • 9[4]Sharma U, Atri S, Sharma MC, et al . Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn Reson Imaging, 2003, 21:145
  • 10[5]Steidle G, Machann J, Claussen CD, et al . Separation of intra- and extramyocellular lipid signals in proton MR spectra by determination of their magnetic field distribution. J Magn Reson, 2002, 154:228

共引文献58

同被引文献36

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部